GlassScriptPhysician profile
Jose David Mercado
NPI 1578096624
$971.73
in general payments reported to CMS, 2019-2025
23 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $140 · 2023: $144 · 2024: $235 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $137.67 | 2021 | |
| Abbvie INC. | $103.49 | 2021-2023 | |
| Shield Therapeutics INC | $88.61 | 2023-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $62.22 | 2021-2025 | |
| Coopersurgical, INC. | $57.35 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $57.23 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $56.72 | 2025 | Acessa Provu System, Aptima, Novasure |
| Meditrina | $48.34 | 2022-2024 | |
| Organon LLC | $47.33 | 2021-2024 | |
| Astellas Pharma US INC | $46.49 | 2024 | Veozah |
| Genzyme Corporation | $42.94 | 2025 | |
| Gynesonics, INC. | $38.70 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Glaxosmithkline, LLC. | $27.05 | 2023 | Nucala |
| Sage Therapeutics, LLC | $24.53 | 2023 | |
| Aerin Medical INC. | $19.89 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $18.27 | 2022 | |
| Smith+Nephew, INC. | $16.95 | 2024 | Stravix |
| Daiichi Sankyo INC. | $14.72 | 2022 | |
| Minerva Surgical, INC | $13.93 | 2025 | |
| Guard Medical INC. | $13.63 | 2024 | Npseal Large |
| Exeltis, USA INC. | $12.15 | 2021 | |
| Agile Therapeutics, INC. | $11.85 | 2022 | |
| Merck Sharp & Dohme LLC | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Mercado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.